Varian Medical Systems has announced it has signed an agreement to acquire ACCEL Instruments, a privately-held supplier of proton therapy systems for cancer treatment and scientific research instruments.
“With this acquisition we can meet the needs of customers who have begun to ask us for proton therapy capabilities that supplement their existing radiotherapy systems,” said Tim Guertin, president and CEO of Varian Medical Systems.
“This leverages our existing technology in treatment planning, image guidance and cancer informatics and it enables Varian to offer all the products needed for delivering proton therapy.We expect that we can build a several hundred million dollar proton therapy business over time.”
